Issue of Warrants to IPF Funding Update | 28-Mar-2024 | 07:00 | RNS |
Faron´s Annual Report 2023 | 26-Mar-2024 | 10:00 | RNS |
Additional Positive Data from Phase 1 of BEXMAB | 18-Mar-2024 | 07:00 | RNS |
Notice of Annual General Meeting 2024 | 13-Mar-2024 | 14:00 | RNS |
Financial Statement January 1 to December 31 2023 | 13-Mar-2024 | 07:00 | RNS |
Binding commitments for convertible loans | 04-Mar-2024 | 07:00 | RNS |
Replacement - Update to 2024 Financial Calendar | 28-Feb-2024 | 16:00 | RNS |
Update to Faron’s Financial C... | 27-Feb-2024 | 18:00 | RNS |
Continued Negotiations Regarding Events of Default | 21-Feb-2024 | 14:00 | RNS |
Events of Default | 19-Feb-2024 | 10:30 | RNS |
Further re: Exercise of options | 31-Jan-2024 | 07:00 | RNS |
BEXMAB Insights into Patient Profiles | 25-Jan-2024 | 07:00 | RNS |
Exercise of options - Issue of equity | 19-Jan-2024 | 13:00 | RNS |
First Patient Dosed in Ph 2 of the BEXMAB Trial | 09-Jan-2024 | 07:00 | RNS |
Faron’s Financial Calendar fo... | 22-Dec-2023 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 137.50p |
Change Today | -2.50p |
% Change | -1.79 % |
52 Week High | 350.00 |
52 Week Low | 125.00 |
Volume | 40,251 |
Shares Issued | 68.81m |
Market Cap | £94.61m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 0 |
Buy | 1 |
Neutral | 0 |
Sell | 1 |
Strong Sell | 1 |
Total | 3 |
No dividends found |
Time | Volume / Share Price |
14:16 | 10 @ 135.00p |
14:16 | 208 @ 140.00p |
14:16 | 54 @ 135.00p |
11:46 | 25,000 @ 137.59p |
13:20 | 7 @ 137.00p |
You are here: research